Senate HELP Committee: Criminal contempt proceedings against Ralph de la Torre regarding Steward Health Care bankruptcy 2025

September 12, 2024: The Empty Chair at the Dirksen Senate Office Building

On the morning of September 12, 2024, the Senate Committee on Health, Education, Labor, and Pensions (HELP) convened in the Dirksen Senate Office Building for a hearing titled “Examining the Bankruptcy of Steward Health Care: How Management Decisions Have Impacted Patient Care.” At the witness table, a single chair stood empty. In front of it, a placard bore the name of the witness commanded to appear: **Dr. Ralph de la Torre**. This absence marked a rare escalation in congressional oversight. For the time since 1981, the HELP Committee had issued a subpoena to compel a witness’s testimony. Dr. de la Torre, the CEO of Steward Health Care, that subpoena.

The Refusal to Appear

In the week leading up to the hearing, legal correspondence between de la Torre’s counsel and the committee made it clear the CEO would not attend. On September 4, 2024, de la Torre’s attorney, Alexander Merton, sent a letter to Committee Chair Bernie Sanders characterizing the scheduled hearing as a “pseudo-criminal proceeding.” The letter argued that because of ongoing bankruptcy processes and federal investigations, de la Torre’s participation would violate his constitutional rights. Merton wrote that the committee appeared determined “not to gather facts, to convict Dr. de la Torre in the eyes of public opinion.” The committee rejected these objections, noting that a witness cannot unilaterally decide whether a congressional subpoena is valid. Senator Bill Cassidy, the committee’s Ranking Member, reinforced the bipartisan nature of the summons, stating, “A witness cannot disregard and evade a duly authorised subpoena.”

“Healthcare Terrorists”

Senator Sanders opened the hearing with a blistering assessment of Steward’s management. He directed the room’s attention to the empty chair and the financial data his staff had prepared. Sanders contrasted the collapse of Steward’s 30-hospital network, which left patients in Massachusetts, Louisiana, and other states without serious care, with the personal enrichment of its CEO. Sanders stated that while hospitals absence basic supplies, de la Torre had extracted hundreds of millions of dollars from the company. “When I hear my colleagues from across America here talk about the deficiencies in the healthcare system, it is glowingly clear to me that the executives of Steward Health are healthcare terrorists,” Sanders said. “They are killing our patients, they are killing our communities and they need to be held accountable.”

The Financial Backdrop: Yachts vs. Patient Care

The committee presented specific financial metrics to illustrate the between de la Torre’s lifestyle and the conditions in his hospitals.

Sanders displayed photographs of the 190-foot *Amaral*, noting that its purchase coincided with the period when Steward hospitals began failing to pay vendors for essential medical supplies.

Voices from the Frontline

While de la Torre remained absent, other witnesses provided testimony on the human cost of Steward’s financial engineering. The panel included nurses and local officials who described a system in collapse. Ellen MacInnis, a nurse at St. Elizabeth’s Medical Center in Boston, testified about the “chronic understaffing” and the unavailability of basic equipment. She described how nurses were forced to scour the hospital for supplies that vendors had stopped delivering due to non-payment. Audra Sprague, a former nurse at Nashoba Valley Medical Center, detailed the closure of her facility. She recounted the “chaos” of trying to care for patients without adequate resources, stating that Steward’s management had “created a hole in our community.” From Louisiana, State Representative Michael Echols and West Monroe Mayor Staci Mitchell testified about the impact on Glenwood Regional Medical Center. Echols described the situation as a “public health emergency,” citing instances where the hospital was put in “immediate jeopardy” status by regulators due to dangerous conditions.

The route to Contempt

The hearing concluded with a unified resolve from the committee members. Senator Cassidy, a physician himself, expressed his dismay at the testimony and the CEO’s refusal to answer for it. “It is time for Dr. de la Torre to answer them before Congress and the American people,” Cassidy said. Sanders announced that the committee would not let the defiance stand. He prepared the committee for a vote to hold Ralph de la Torre in both civil and criminal contempt of Congress, a process that would formally begin the following week. The empty chair, intended by de la Torre’s legal team to be a shield against self-incrimination, instead became the focal point for a rare bipartisan rebuke of corporate impunity.

July 25, 2024: The Bipartisan Authorization

On the morning of July 25, 2024, the Senate Committee on Health, Education, Labor, and Pensions (HELP) convened in the Dirksen Senate Office Building to execute a procedural maneuver unseen in the committee’s operations for more than four decades. Under the leadership of Chairman Bernie Sanders (I-Vt.) and Ranking Member Bill Cassidy (R-La.), the committee moved to compel the testimony of Dr. Ralph de la Torre, the CEO of Steward Health Care, following his repeated refusals to appear voluntarily.

The session resulted in two distinct roll call votes that established the legal foundation for the subsequent contempt proceedings., the committee voted 20, 1 to formally authorize an investigation into the bankruptcy of Steward Health Care. Second, and more contentiously, the committee voted 16, 4 to problem a subpoena requiring de la Torre’s presence at a hearing scheduled for September 12, 2024.

Breaking a 43-Year Precedent

The authorization marked a significant escalation in congressional oversight. According to committee records, this was the time the Senate HELP Committee had issued a subpoena since 1981. For over 40 years, the panel had relied on voluntary compliance from witnesses, a tradition that de la Torre’s legal team had in earlier correspondence as a reason to avoid compulsory process. The bipartisan nature of the vote, yet, signaled a collapse in patience across party lines regarding Steward’s financial opacity.

Chairman Sanders framed the vote as a necessary response to “arrogance” from the corporate sector. “Time and time and time again, he has arrogantly refused,” Sanders stated during the executive session, referring to the CEO’s rejection of invitations sent on June 25 and subsequent dates. Ranking Member Cassidy supported the measure, characterizing the subpoena as a “last resort” necessitated by the witness’s obstruction.

The Vote Breakdown

The between the investigation vote (20, 1) and the subpoena vote (16, 4) highlights the procedural nuances of the committee’s action. While near-unanimous support existed for investigating the hospital system’s collapse, four members dissented on the specific use of the subpoena power against a private individual. even with this opposition, the 16 affirmative votes cleared the threshold required by Senate rules to compel testimony.

Scope of the Compulsion

The subpoena authorized by the committee was specific in its demands. It directed de la Torre to appear at the Dirksen Senate Office Building on September 12, 2024, to testify at a hearing titled “Examining the Bankruptcy of Steward Health Care: How Management Decisions Have Impacted Patient Care.” The scope was tailored to address the management decisions that led to the filing of Chapter 11 bankruptcy in May 2024, which had placed 31 hospitals across eight states in financial jeopardy.

By issuing the subpoena, the committee formally rejected the arguments presented by de la Torre’s counsel, who had claimed that testifying would violate a directive from the company barring him from discussing the bankruptcy and would infringe upon his constitutional rights. The committee’s legal advisors maintained that the Senate’s investigative authority superseded such corporate directives, setting the stage for the constitutional clash that would unfold in September.

“We had no choice to move forward… If you a Congressional subpoena, you be held accountable.”
, Joint Statement by Sens. Sanders and Cassidy

This July 25 authorization provided the strict legal predicate for the criminal contempt resolution that would follow later in the year. Without this valid, bipartisan vote to compel testimony, the subsequent referral to the U. S. Attorney for the District of Columbia would have absence the necessary procedural standing.

2 U. S. C. § 192: The Statutory Framework for Criminal Contempt of Congress

The empty chair at the September 12 hearing did not represent a scheduling conflict; it triggered a specific federal statute designed to enforce the legislative branch’s investigative authority. The legal method activated by Ralph de la Torre’s refusal to appear is **2 U. S. C. § 192**, a law that dates back to 1857. This statute serves as the primary criminal enforcement tool for Congressional subpoenas, transforming a procedural defiance into a federal misdemeanor with mandatory penalties.

The Text and Penalties of Section 192

Under 2 U. S. C. § 192, any person summoned as a witness by a House of Congress who “willfully makes default” or “refuses to answer any question pertinent to the question under inquiry” is guilty of a misdemeanor. The statute is rigid regarding punishment. Unlike modern federal offenses where judges have vast sentencing discretion, Section 192 mandates imprisonment. The text specifies that a convicted offender shall be punished by a fine of not more than $1, 000 nor less than $100 and imprisonment in a “common jail” for **not less than one month** nor more than twelve months. This mandatory minimum incarceration provision distinguishes criminal contempt from civil remedies, which are designed only to coerce testimony rather than punish past conduct.

The Certification method: 2 U. S. C. § 194

While Section 192 defines the crime, **2 U. S. C. § 194** establishes the procedural conveyor belt that moves a contempt citation from a committee room to a federal grand jury. The process involves strict statutory steps: 1. **Committee Report:** The committee (in this case, HELP) must vote to report the failure of the witness to the full chamber. 2. **Chamber Certification:** The presiding officer of the Senate (or Speaker of the House) must certify the statement of facts to the United States Attorney for the District of Columbia. 3. **Prosecutorial Duty:** The statute explicitly states it shall be the “duty” of the U. S. Attorney to bring the matter before a grand jury, although modern legal interpretations by the Department of Justice frequently assert prosecutorial discretion in this phase.

Application to Ralph de la Torre

In the case of *United States Senate Committee on Health, Education, Labor, and Pensions v. Ralph de la Torre*, the violation centered on the “willful default” clause of Section 192, specifically, the failure to appear. De la Torre’s legal team, led by attorney Alexander Merton, attempted to preempt the hearing with a letter on September 4, 2024. They argued that the hearing was a “pseudo-criminal proceeding” designed to frame de la Torre as a scapegoat for the widespread failures of the Massachusetts health care system. They further contended that a federal court order related to Steward Health Care’s bankruptcy prohibited him from discussing company matters, and invoked his Fifth Amendment privilege against self-incrimination. The Committee rejected these defenses on two primary grounds: * **The “Blanket” Fifth Amendment Claim:** Longstanding legal precedent establishes that a witness cannot refuse to appear based on a blanket assertion of Fifth Amendment rights. The witness must appear, take the oath, and invoke the privilege in response to specific questions. By failing to walk into the hearing room, de la Torre forfeited the opportunity to selectively invoke his rights, placing him in default. * **Bankruptcy vs. Congressional Oversight:** The Committee maintained that a bankruptcy court’s administrative orders do not supersede the Article I oversight powers of the United States Congress. The “pertinency” of the inquiry, the collapse of a hospital system affecting public health, was deemed to override the corporate gag orders by the defense.

The route to Referral

The activation of Section 192 against de la Torre proceeded with unusual speed and unanimity, reflecting the bipartisan anger over the Steward Health Care collapse. * **September 19, 2024:** The HELP Committee voted **20-0** to adopt two resolutions: one for civil enforcement (to force testimony) and one for criminal contempt (to punish the failure to appear). * **September 25, 2024:** The full Senate passed the criminal contempt resolution by **unanimous consent**. This marked the time since 1971 that the full Senate voted to hold an individual in criminal contempt, and the time in modern history that the HELP Committee utilized this power. Following the Senate vote, the resolution was certified and transmitted to the U. S. Attorney for the District of Columbia, escalating the dispute from a legislative standoff to a chance federal criminal case.

Civil vs. Criminal Contempt

The Senate HELP Committee simultaneously pursued both civil and criminal contempt. Understanding the distinction is important to analyzing the legal pressure applied to de la Torre.

“If you a congressional subpoena, you be held accountable, no matter who you are or how well-connected you may be.”
, Senator Bernie Sanders (I-VT), Senate Floor, September 25, 2024.

The invocation of Section 192 signaled that the Senate viewed de la Torre’s absence not as a legal dispute to be litigated, as an affront to the institution itself. By bypassing the civil route as the sole remedy and immediately voting for criminal contempt, the Committee removed the “stall tactic” option frequently used by corporate executives, placing de la Torre in immediate legal jeopardy.

The Fifth Amendment Defense: Analyzing Counsel Alexander Merton’s Legal Argument

On September 4, 2024, attorneys for Ralph de la Torre submitted a formal response to the Senate HELP Committee’s subpoena, outlining a legal strategy centered on the Fifth Amendment’s protection against self-incrimination. Alexander Merton, a partner at Quinn Emanuel Urquhart & Sullivan representing de la Torre, argued that the committee’s demand for testimony constituted a “pseudo-criminal proceeding” rather than a legitimate legislative inquiry. In a letter addressed to Chairman Bernie Sanders, Merton asserted that the senators had already determined his client’s guilt and intended to use the hearing solely to “ambush” de la Torre.

The defense team’s primary legal contention rested on the assertion that compelling de la Torre to appear would violate his constitutional rights. Merton argued that because members of the committee had publicly called for criminal investigations into Steward Health Care’s bankruptcy, any testimony provided would be used to build a criminal case against him. The letter stated:

“It is not within this Committee’s purview to make predeterminations of alleged criminal misconduct under the auspices of an examination into Steward’s bankruptcy proceedings… [The Committee seeks] to convict Dr. de la Torre in the eyes of public opinion.”

The “Blanket Refusal” Controversy

A central point of friction involved the method of invoking the Fifth Amendment. Senate rules and judicial precedents generally require a witness to appear in person and assert their privilege against self-incrimination in response to specific questions. De la Torre’s legal team attempted to bypass this requirement, arguing that a physical appearance would serve no purpose other than to create a “televised circus” where the CEO would repeatedly invoke his rights. Merton contended that forcing de la Torre to attend simply to plead the Fifth was an abuse of congressional power designed to humiliate his client.

The committee rejected this interpretation. In a rare display of bipartisan unity, Chairman Sanders and Ranking Member Bill Cassidy (R-La.) maintained that a “blanket refusal” to appear is not a valid legal defense. They long-standing congressional procedures establishing that the Fifth Amendment protects a witness from answering incriminating questions does not shield them from the obligation to show up. Senator Cassidy noted that de la Torre’s refusal to even enter the room the fundamental authority of the legislative branch.

Conflict with Bankruptcy Court Orders

Beyond the constitutional argument, Merton introduced a secondary defense related to ongoing federal litigation. He claimed that a federal court order issued during Steward Health Care’s bankruptcy mediation prohibited de la Torre from discussing specific financial details. The defense argued that testifying before the Senate would force de la Torre to violate this judicial gag order, placing him in legal jeopardy regardless of his answers. The committee dismissed this argument as well, stating that a congressional subpoena supersedes such civil mediation orders and that the scope of the hearing was broad enough to allow for testimony without breaching the bankruptcy court’s specific restrictions.

Committee Vote and Legal Consequences

The Senate HELP Committee found Merton’s arguments unpersuasive. On September 19, 2024, the panel voted 20-0 to hold de la Torre in both civil and criminal contempt, the time the committee had taken such a step in modern history. The unanimous vote signaled that the Senate viewed the “pseudo-criminal” defense as a direct challenge to its oversight capabilities. Following the committee’s action, the full Senate voted unanimously on September 25 to refer the criminal contempt resolution to the U. S. Attorney for the District of Columbia, escalating the dispute from a political standoff to a federal criminal matter.

September 19, 2024: The Unanimous Referral

On the morning of September 19, 2024, the Senate HELP Committee convened in an executive session that would mark a definitive escalation in its confrontation with Ralph de la Torre. In a rare display of bipartisan unity during a polarized congressional era, the committee voted 20-0 to adopt two separate resolutions holding the Steward Health Care CEO in contempt. This unanimous action signaled the collapse of de la Torre’s legal blockade and set the stage for the criminal contempt prosecution of a witness by the full Senate in over half a century.

The Two-Track Legal Strategy

The committee did not rely on a single enforcement method. Instead, Chair Bernie Sanders and Ranking Member Bill Cassidy engineered a dual-track method designed to maximize legal pressure. The twenty senators present voted affirmatively on two distinct resolutions, each serving a specific judicial purpose: * **Civil Enforcement Resolution:** This measure instructed the Senate Legal Counsel to initiate a civil lawsuit in the U. S. District Court for the District of Columbia. The objective was to obtain a judicial order compelling de la Torre to provide the subpoenaed testimony and documents, stripping away his ability to delay through procedural objections. * **Criminal Contempt Resolution:** This measure referred the matter to the U. S. Attorney for the District of Columbia for criminal prosecution under 2 U. S. C. § 192. Unlike the civil action, which sought compliance, this resolution sought punishment for the act of defiance itself, carrying chance penalties of fines and imprisonment. The adoption of both resolutions simultaneously closed off de la Torre’s escape routes. While civil enforcement could take months to litigate, the criminal referral created immediate personal jeopardy for the CEO.

Bipartisan Condemnation

The 20-0 vote count underscored the total isolation of de la Torre on Capitol Hill. In a committee frequently divided by ideological differences regarding healthcare policy and labor rights, the refusal of a corporate witness to answer for the collapse of a hospital system bridged the partisan divide. Chair Bernie Sanders framed the vote as a defense of the legislative branch’s constitutional authority. “Dr. de la Torre is not above the law,” Sanders stated immediately following the vote. “If you a congressional subpoena, you be held accountable, no matter who you are.” Ranking Member Bill Cassidy, a physician, reinforced the of the CEO’s absence. “The Committee sought testimony about the financial decisions made by Dr. de la Torre as CEO of Steward Health Care,” Cassidy noted. “We had no choice to move forward with both civil enforcement of the subpoena and criminal charges.”

Historical Significance

The September 19 vote was not a procedural step; it was a historic anomaly. This action represented the time in modern American history that the HELP Committee had issued a civil or criminal contempt resolution. The rarity of the move highlighted the severity of the allegations against Steward Health Care and the perceived arrogance of its CEO’s refusal to engage with the oversight process.

Defense Reaction

Following the committee’s decisive action, a spokesperson for de la Torre issued a statement characterizing the proceedings as a “pseudo-criminal proceeding” designed to convict the CEO in the court of public opinion. The defense maintained that the committee was weaponizing its oversight powers to punish de la Torre for invoking his Fifth Amendment rights, a legal theory the committee had explicitly rejected in its deliberations. This defiant stance, yet, did nothing to fracture the committee’s unity, as the resolutions moved immediately to the Senate floor for final consideration.

September 25, 2024: The Unanimous Consent of the Senate

On the afternoon of September 25, 2024, the United States Senate convened to execute a procedural action unseen in that chamber for over five decades. Following the unanimous recommendation of the HELP Committee, Chairman Bernie Sanders (I-Vt.) took to the Senate floor to call up **Senate Resolution 837**. The resolution carried a singular, punitive objective: to certify the report of the HELP Committee regarding the refusal of Dr. Ralph de la Torre to appear before Congress and to refer the matter to the United States Attorney for the District of Columbia for criminal prosecution. The vote did not require a roll call. In a demonstration of the total collapse of de la Torre’s political capital, the measure passed by **unanimous consent**. Not a single Senator from either party objected, debated the merit of the CEO’s defense, or moved to delay the proceedings. The absence of dissent on the floor mirrored the 20-0 vote in committee, solidifying a bipartisan consensus that the Steward Health Care executive’s defiance of a subpoena constituted a direct insult to the legislative branch.

The Floor Proceedings

Before the gavel fell, key members of the HELP Committee delivered blistering remarks that framed the vote not as a procedural need, as a moral imperative. Chairman Sanders, addressing the chamber, stripped away the legal complexities of the Fifth Amendment defense offered by de la Torre’s counsel.

“Dr. de la Torre is not above the law. If you a congressional subpoena, you be held accountable no matter who you are or how well connected you may be.”

Senator Ed Markey (D-Mass.), whose constituents bore the brunt of Steward’s hospital closures in Massachusetts, provided the most visceral condemnation of the day. He characterized the CEO’s wealth as illegitimate, directly linking the executive’s luxury assets to the degradation of patient care.

“Dr. de la Torre is using his blood-soaked gains to hide behind corporate lawyers instead of responding to the United States Senate’s demands for actions. while he tries to run and hide, Dr. de la Torre is revealing himself for what he truly is, a physician who places personal gain over his duty to do no harm.”

Senate Resolution 837: The Mechanics of Referral

The passage of S. Res. 837 triggered the statutory method outlined in 2 U. S. C. § 192 and § 194. Unlike a civil contempt citation, which seeks to coerce testimony through fines or imprisonment until compliance is achieved, this criminal referral is punitive. It transferred jurisdiction from the legislative branch to the executive branch. Upon adoption, the resolution mandated the President of the Senate to certify the committee’s report and transmit it to the United States Attorney for the District of Columbia, Matthew Graves. The statute leaves the prosecutor with a “duty” to bring the matter before a grand jury, though the Department of Justice retains prosecutorial discretion on whether to pursue charges. The resolution’s text was explicit. It did not request an investigation; it formally de la Torre for his failure to appear on September 12, 2024, as required by the subpoena issued on July 25, 2024. This marked the time since 1971 that the full Senate voted to hold an individual in criminal contempt, a historical rarity that show the severity of the confrontation.

The Defense’s Reaction

Immediately following the Senate’s action, a spokesperson for Ralph de la Torre issued a statement condemning the vote as a “pseudo-criminal proceeding.” The defense team argued that the Senate had ignored de la Torre’s assertion of his Fifth Amendment rights, framing the contempt citation as an unconstitutional attempt to punish him for exercising a fundamental legal protection. “The way the vote was presented today makes no mention that Dr. de la Torre asserted his constitutionally protected right to invoke the 5th Amendment,” the spokesperson stated. This public rebuttal signaled that the legal battle would shift from the Senate hearing room to federal court, where the validity of a blanket Fifth Amendment assertion in response to a congressional subpoena would be the central point of contention.

Timeline of the Contempt Escalation

The speed at which the Senate moved from subpoena to criminal referral highlights the urgency felt by the HELP Committee. The following table details the serious dates in the escalation of proceedings against Ralph de la Torre.

Historical Context: A 53-Year Gap

The passage of S. Res. 837 ended a 53-year period during which the Senate refrained from using its criminal contempt power. The last instance occurred in 1971. While the House of Representatives has frequently used criminal contempt citations —most notably against figures such as Steve Bannon and Peter Navarro—the Senate has historically preferred civil enforcement method to compel testimony. The decision to bypass civil enforcement and move directly to criminal contempt reflects the HELP Committee’s assessment that de la Torre’s testimony was no longer the primary goal; accountability for the defiance itself had taken precedence. By invoking the criminal statute, the Senate signaled that the breach of process was complete and irreversible, leaving the Department of Justice to determine the legal consequences.

Financial Forensics: Deconstructing the $9 Billion Debt Load

By the time Steward Health Care filed for Chapter 11 protection in the Southern District of Texas on May 6, 2024, the company’s balance sheet had ceased to function as a record of operations and had become a crime scene of financial engineering. The bankruptcy filings revealed a liability stack totaling approximately $9 billion, a figure that stunned creditors and regulators alike. This debt load was not the result of sudden market shifts or a pandemic-induced revenue collapse; it was the mathematical inevitability of a decade-long extraction strategy designed to prioritize private equity returns over solvency.

The Liability Architecture

The $9 billion figure was not a monolith a stratified accumulation of obligations, each representing a different phase of the company’s hollowing out. Forensic analysis of the bankruptcy schedules and -day motions exposes four primary categories of debt that suffocated the hospital system.

The Sale-Leaseback Catalyst (2016)

The engine of Steward’s insolvency was ignited in October 2016. Under the ownership of Cerberus Capital Management and the leadership of Ralph de la Torre, Steward executed a massive sale-leaseback transaction with Medical Properties Trust (MPT), a Birmingham-based Real Estate Investment Trust (REIT). In this deal, MPT paid $1. 25 billion to acquire the real estate assets of Steward’s Massachusetts hospitals.

While presented publicly as a capital infusion to fund national expansion, the transaction fundamentally altered the hospital system’s DNA. Steward went from being an owner of its facilities to a tenant with a crippling, long-term rent load. The master lease agreement included aggressive escalator clauses, ensuring that rent payments would rise annually regardless of hospital revenue or patient volume. By the time of the bankruptcy filing, these lease obligations had ballooned to $6. 6 billion over the remaining life of the contracts.

The Dividend Extraction

The liquidity generated by the 2016 MPT transaction did not remain in the hospitals to upgrade equipment or shore up reserves. Instead, it flowed immediately out of the company to its private equity owners and executives. Financial records indicate that shortly after the deal closed, Steward paid a dividend of approximately $719 million to Cerberus Capital Management.

Simultaneously, Steward’s management team, led by de la Torre, received a payout of approximately $71 million. This extraction occurred in the same fiscal year that Steward reported a net loss of roughly $300 million. The pattern repeated in 2021, following Cerberus’s exit. even with the system’s deepening financial distress, a dividend of $111 million was paid to shareholders, including de la Torre, further depleting the cash reserves needed for operations.

Vendor Arrears and Operational Collapse

As cash was siphoned out for dividends and rent, Steward began to aggressively stretch its accounts payable. By early 2024, the system owed nearly $1 billion to vendors, creating a supply chain emergency that directly endangered patient safety. The bankruptcy creditor matrix reads like a directory of the medical industry, listing unpaid debts to essential service providers:

• Sodexo: Owed $1. 9 million for food and facilities services.
• Medtronic: Owed $1. 8 million for pacemakers and insulin pumps.
• Philips Healthcare: Owed $766, 000 for diagnostic imaging equipment.
• Arthrex: Owed $497, 000 for orthopedic surgical supplies.

The consequences of these arrears were visceral. In one instance, a vendor repossessed embolization coils, serious devices used to stop internal bleeding, from St. Elizabeth’s Medical Center just weeks before a patient died from postpartum. In Florida, an extermination company sued for $1. 6 million in unpaid bills after Rockledge Regional Medical Center experienced a bat infestation so severe that staff reported guano smells in the ICU.

The “FILO” Desperation

In the final months before the collapse, Steward turned to ” -In, Last-Out” (FILO) financing, a form of high-interest distress lending. In June 2024, the company secured $225 million in debtor-in-possession (DIP) financing from a group of lenders including Sound Point Capital and Brigade Agency Services. These loans, secured by the few remaining unencumbered assets, came with onerous terms that reflected the lenders’ absence of confidence in Steward’s survival. The financing was not a to stability; it was a final lifeline to fund the liquidation process, ensuring that bankruptcy professionals and secured lenders would be paid while patients and pensioners faced uncertainty.

The $9 billion debt load was not a number; it was the structural artifact of a business model that treated community hospitals as financial extraction vehicles. By separating the operating companies from their real estate and loading the former with rent while stripping the cash, the architects of this scheme ensured that when the collapse came, the wreckage would fall entirely on the public, the patients, and the workforce.

The MPT Sale-Leaseback: Extraction of $1. 2 Billion in Real Estate Value

The financial destabilization of Steward Health Care can be traced directly to a single, major transaction executed on September 26, 2016. On that date, Steward closed a $1. 25 billion deal with Medical Properties Trust (MPT), a Birmingham, Alabama-based real estate investment trust (REIT). While publicly billed as a capital infusion to “fund expansion” and “pay off debt,” the transaction functioned primarily as a method to monetize the hospital system’s tangible assets for the immediate benefit of its private equity owners and executive management.

The Mechanics of the 2016 Transaction

The agreement fundamentally altered the hospital system’s balance sheet by severing the ownership of its physical facilities from its operations. Under the terms of the deal, MPT acquired the real estate of nine Steward hospitals in Massachusetts for $1. 2 billion. also, MPT invested $50 million for a minority equity stake in the company, reported between 5% and 9. 9%.

Prior to this transaction, Steward owned its hospital buildings and land, meaning it had no rent obligations for these facilities. The sale-leaseback arrangement immediately converted these assets into long-term liabilities. Steward received a lump sum of cash simultaneously signed master lease agreements that obligated the system to pay rent on the very buildings it had just sold. These leases included escalator clauses, ensuring that rent payments would increase annually regardless of the hospitals’ operating performance or revenue fluctuations.

Distribution of Proceeds: The $790 Million Payout

The influx of $1. 25 billion did not result in a corresponding strengthening of Steward’s long-term financial health. Instead, the majority of the proceeds were extracted from the company in the form of dividends. According to bankruptcy filings and reports by the Senate HELP Committee, approximately $790 million was paid out to shareholders immediately following the deal.

Cerberus Capital Management, the private equity firm that had acquired the original Caritas Christi system in 2010 for roughly $246 million in cash, received the lion’s share of this distribution. Reports indicate Cerberus recouped its initial investment and secured hundreds of millions in profit in a single stroke. The Wall Street Journal reported that Cerberus received a dividend of approximately $719 million in 2016. Simultaneously, Steward’s management team, led by CEO Ralph de la Torre, received a payout of approximately $71 million.

“The deal results in MPT waiving its claim of $7. 5 billion, including $6. 6 in future rent obligations… Steward CEO Ralph de la Torre is expected to be held in contempt by lawmakers this week.”
, HealthLeaders Media, September 17, 2024

Financial Impact: Trading Assets for Liabilities

The immediate consequence of the 2016 deal was a dramatic shift in Steward’s financial structure. The system traded its most valuable tangible assets, real estate worth $1. 2 billion, for a massive cash pile that was promptly drained by shareholder payouts. In exchange, the hospitals were saddled with rent payments that would balloon over the eight years.

By the time Steward filed for bankruptcy in May 2024, its lease obligations to MPT had grown to approximately $6. 6 billion over the life of the leases. The annual rent load for the system had reached roughly $341 million. This fixed cost created a “ticking time bomb” scenario: any dip in patient volume or reimbursement rates would leave the hospitals unable to cover their rent, leading to the vendor payment delays and supply absence that plagued the system in 2023 and 2024.

Senate HELP Committee Findings

The Senate HELP Committee has identified this 2016 transaction as the “original sin” of Steward’s collapse. In the September 12, 2024 hearing, Chairman Bernie Sanders characterized the deal not as a standard business strategy, as a “looting” of the healthcare system. The committee’s investigation highlighted that while the hospitals posted a net loss of approximately $300 million in 2016, the private equity owners and executives successfully extracted nearly $800 million in cash.

The committee’s scrutiny focuses on the between the wealth generated for the owners and the debt imposed on the hospitals. While Ralph de la Torre and Cerberus exited the transaction with substantial liquidity, the individual hospitals, such as St. Elizabeth’s Medical Center and Carney Hospital, were left to service lease payments that consumed an unsustainable percentage of their operating revenue. This structural deficit made it mathematically impossible for the hospitals to invest in necessary staffing, equipment, and infrastructure, directly contributing to the patient care crises that precipitated the federal investigation.

Cerberus Capital Management: The 2010 Acquisition and $800 Million Exit Profit

The 2016 Real Estate Liquidation Event

While Cerberus Capital Management acquired the struggling Caritas Christi Health Care system in 2010 for approximately $246 million in cash (plus assumed liabilities), the financial architecture that would eventually cripple Steward Health Care was engineered six years later. In 2016, Cerberus executed a massive sale-leaseback transaction with Medical Properties Trust (MPT), a real estate investment trust based in Alabama. This deal fundamentally altered Steward’s balance sheet by selling the underlying real estate of its Massachusetts hospitals to MPT for $1. 25 billion.

This transaction provided immediate liquidity stripped the hospital system of its most valuable tangible assets. According to data released by the Senate HELP Committee in 2024, Cerberus used the proceeds from this real estate sale not to stabilize the hospitals’ long-term operations, to pay itself a one-time cash dividend of $484 million. This single payout allowed the private equity firm to recoup its initial investment nearly two times over, four years before it would formally exit the company. In exchange for this cash infusion, Steward Health Care was locked into a master lease agreement requiring millions of dollars in monthly rent payments, obligations that would regardless of patient volume or revenue fluctuations.

The 2020 Exit and the Convertible Note

In May 2020, as the COVID-19 pandemic began to healthcare systems globally, Cerberus moved to divest its remaining equity in Steward. The firm transferred its ownership stake to a management group led by CEO Ralph de la Torre. The terms of this exit, scrutinized heavily during the 2024 Senate proceedings, were structured to maximize Cerberus’s final return while load the hospital chain with further debt.

Instead of a simple cash sale, Cerberus exchanged its equity for a $350 million convertible promissory note. This financial instrument deferred the payout secured Cerberus’s claim on Steward’s future capital. The Senate investigation revealed that this note was not paid by the doctors or management group from their own funds. Instead, in January 2021, Medical Properties Trust, Steward’s landlord, loaned the hospital system approximately $335 million specifically to buy out the Cerberus note. This maneuver allowed Cerberus to fully cash out, leaving Steward with the liability of repaying MPT.

Calculating the $800 Million Profit

The total profit realized by Cerberus Capital Management became a focal point of the Senate HELP Committee’s 2024 investigation. By aggregating the 2016 dividend and the 2021 note payoff, investigators estimated that Cerberus generated approximately $800 million in total profit from its decade-long ownership of Steward. This figure stands in clear contrast to the financial health of the hospital system it left behind, which by 2024 was facing over $9 billion in total liabilities.

The “Looting” Allegations and the $111 Million Dividend

The exit process also facilitated significant payouts to Steward’s executives. Senate documents show that in January 2021, concurrent with the Cerberus buyout, Steward Health Care paid a $111 million dividend to its new owners, a group that included Ralph de la Torre. This payment occurred even with the system’s precarious financial position and the ongoing pressures of the pandemic. Critics, including Senator Elizabeth Warren, characterized this sequence of transactions as “looting,” arguing that the private equity model allowed investors and executives to extract hundreds of millions of dollars while leaving the hospitals with no assets and unsustainable rent load.

“Cerberus and its private equity executives received $800 million in profits… while leaving the facilities with long-term liabilities that are magnifying, if not creating, the current emergency.”
, Letter from Senators Warren and Markey to Cerberus CEO Stephen Feinberg, February 15, 2024

Legacy of the Leveraged Exit

The structural damage inflicted by these transactions became undeniable by 2024. The sale-leaseback model meant that Steward did not own the land under its own emergency rooms, forcing it to pay rent to MPT even as it struggled to buy medical supplies. The $800 million extracted by Cerberus and the subsequent debt loaded onto the system by the management buyout removed the capital cushion necessary to weather operational storms. When the Senate HELP Committee convened in September 2024, the “Cerberus era” was not as a period of revitalization, as the origin point of the insolvency that would eventually threaten the care of millions of patients.

Executive Compensation: The $250 Million Payout to Insiders During Insolvency

The Quarter-Billion Dollar Extraction

While Steward Health Care’s hospitals faced chronic absence of life-saving equipment and vendors went unpaid, a small circle of executives and insiders extracted massive sums of capital from the system. Senate HELP Committee investigations and subsequent bankruptcy filings revealed that Ralph de la Torre and entities he controlled received at least $250 million in total compensation, dividends, and other payments between 2020 and 2024. This transfer of wealth occurred during a period when the hospital network’s financial health was in freefall, leading to what bankruptcy attorneys later characterized as the systematic “looting” of community assets.

The 2021 Dividend: $111 Million While Insolvent

The most contentious single transaction identified by investigators occurred in January 2021. even with the financial placed on the healthcare system by the COVID-19 pandemic and mounting operational debts, Steward’s board authorized a $111 million dividend payment to its shareholders.

Court filings from the bankruptcy proceedings indicate that Ralph de la Torre personally received approximately $81. 5 million of this distribution. The timing of this payout is central to the criminal contempt proceedings; bankruptcy lawyers for the restructuring team have alleged that the company was already insolvent at the time the dividend was issued. The payment did not reinvest capital into crumbling infrastructure or patient care instead moved cash directly into the private accounts of the ownership group.

The “Amaral” and the “Jaruco”: A $55 Million Flotilla

Following the receipt of the 2021 dividend, de la Torre acquired significant luxury assets. In 2021, he purchased the Amaral, a 190-foot superyacht valued at approximately $40 million. The vessel, formerly known as the Lady Sheridan, features six cabins, a gym, and accommodations for a crew of 15.

Senate investigators also highlighted the purchase of a second vessel, the Jaruco. Described as a 90-foot sportfishing boat, the custom-built marine craft is valued at roughly $15 million. These acquisitions became a focal point during the September 12, 2024, hearing, where Senator Bernie Sanders displayed photographs of the yachts to contrast the CEO’s lifestyle with the conditions inside Steward hospitals, where nurses reported scavenging for supplies.

Corporate Aviation: The Bombardier Global 6000

to marine assets, Steward Health Care funds financed high-end corporate aviation. The company maintained a Bombardier Global 6000, a long-range business jet valued at approximately $62 million. Flight logs analyzed by the committee showed the aircraft was used for travel to luxury destinations, including the Galapagos Islands and the Amalfi Coast, frequently coinciding with de la Torre’s personal schedule rather than hospital business.

A second aircraft, a Dassault Falcon 2000LX, was also part of the fleet. The operational costs for these jets, fuel, crew, hangaring, and maintenance, were borne by the hospital system even as it defaulted on payments to serious vendors, including those supplying surgical instruments and elevator maintenance services.

Pre-Bankruptcy Salaries and Bonuses

The extraction of capital continued up to the moment of the Chapter 11 filing in May 2024. Bankruptcy documents filed in July 2024 revealed that 14 executives received aggregate compensation exceeding $1 million each in the year prior to the collapse.

The Cerberus Precedent: The 2016 Recapitalization

The pattern of extracting dividends from the hospital system was established prior to de la Torre’s majority ownership. In 2016, under the ownership of private equity firm Cerberus Capital Management, Steward executed a sale-leaseback transaction with Medical Properties Trust (MPT). This deal generated cash by selling the hospital real estate and leasing it back at high interest rates.

From the proceeds of this real estate sale, a $719 million dividend was paid to Cerberus., Steward management, including de la Torre, received a payout of approximately $71 million. This transaction stripped the hospitals of their most valuable tangible assets, the land and buildings, and saddled them with long-term rent obligations that would later contribute to the system’s insolvency. Cerberus exited its investment in 2020, transferring its 90% stake to a physician group led by de la Torre in exchange for a convertible note, having realized an estimated $800 million profit from its decade-long involvement.

Legal Characterization: “Pillaging” and “Looting”

The of these payouts has triggered aggressive litigation from the bankruptcy estate. In a lawsuit filed against de la Torre in 2025, the new management of Steward Health Care accused the former CEO of “pillaging” the company. The complaint alleges that de la Torre and a small cadre of insiders breached their fiduciary duties by prioritizing their own enrichment over the solvency of the firm.

“Through their greed and bad faith misconduct, [these insiders] operated Steward with the aim of enriching themselves at the expense of the Company, its creditors, and the patients and communities that Steward served.”
, Steward Health Care Systems LLC v. Ralph de la Torre, et al., Complaint filed in U. S. Bankruptcy Court, Southern District of Texas.

The suit seeks to claw back the $111 million dividend and other payments, arguing they constitute fraudulent transfers made when the company was already unable to pay its debts. These financial provided the evidentiary foundation for the Senate HELP Committee’s of criminal contempt charges, framing the refusal to testify not just as a procedural dispute, as an attempt to evade accountability for a quarter-billion-dollar extraction scheme.

Asset Tracking: The $40 Million ‘Amaral’ Superyacht and Maintenance Costs

The most visible symbol of the capital extraction strategy executed by Ralph de la Torre was not a medical facility, a 190-foot luxury vessel registered in the Cayman Islands. While Steward Health Care hospitals in Massachusetts and Texas rationed life-saving equipment and failed to pay vendors for essential supplies, de la Torre acquired and maintained the *Amaral*, a superyacht valued at approximately $40 million. This asset became a focal point for the Senate HELP Committee’s investigation, representing the direct transfer of healthcare revenue into private luxury holdings.

The Vessel and its Valuation

The *Amaral* (formerly known as the *Lady Sheridan*) is a custom-built motor yacht delivered by the German shipyard Abeking & Rasmussen. It measures 190 feet (58 meters) in length and features a steel hull and aluminum superstructure. The vessel’s interior, designed by Donald Starkey, includes six staterooms capable of accommodating 12 guests, a library, a fitness center, and a sun-deck whirlpool. Senate investigators and bankruptcy filings confirmed the purchase price and valuation. In 2021, shortly after the height of the COVID-19 pandemic, de la Torre purchased the yacht for an estimated $40 million. This acquisition occurred simultaneously with significant financial deterioration within the Steward network. to the *Amaral*, investigators identified a secondary vessel in de la Torre’s flotilla: the *Jaruco*, a 90-foot custom sportfishing boat valued at $15 million. The combined value of these two marine assets, $55 million, exceeded the total unpaid vendor debts of several individual Steward hospitals at the time of their closure.

The Funding method: The 2021 Dividend

The acquisition of the *Amaral* was not funded through external personal wealth, rather through proceeds derived directly from Steward Health Care’s recapitalization. On January 8, 2021, Steward Health Care System LLC authorized a dividend recapitalization distribution of $111 million to its equity holders. This transaction was executed at a time when the hospital system was already facing liquidity challenges. According to a lawsuit filed by the Steward bankruptcy estate in July 2025, de la Torre personally received approximately $81. 5 million of this distribution. Bankruptcy court filings explicitly link this payout to the yacht purchase. The estate’s complaint alleges that “within just a few months” of receiving the $81. 5 million dividend, de la Torre used the funds to acquire the *Amaral*. The timeline established by the Senate HELP Committee shows a direct correlation between the extraction of hospital liquidity and the acquisition of the vessel.

Ownership Structure: The ‘Mullet’ Entities

To hold these assets, de la Torre utilized a complex network of shell entities designed to obfuscate ownership and shield the property from direct liability.

The use of Cayman Islands registration for “Mullet Ltd.” provided tax advantages and anonymity, the operational entity “Mullet LLC” maintained bank accounts in Florida, creating a jurisdictional hook for U. S. investigators. The Senate investigation revealed that these entities were alter egos of de la Torre, with no independent business purpose other than holding his personal luxury assets.

Operational Costs and Maintenance

The initial purchase price of the *Amaral* represented only a fraction of the capital diverted to support it. Industry standards for a vessel of this size estimate annual operational costs at approximately 10% of the value. For the *Amaral*, this amounted to roughly $4 million per year. These costs covered: * Crew Salaries: A permanent crew of 15 staff members, including a captain, engineers, deckhands, and interior staff. * Docking Fees: High-cost berthing in locations such as the Galapagos Islands, Panama, and the Amalfi Coast. * Fuel and Insurance: Substantial recurring expenses required to keep the vessel seaworthy. During the September 2024 HELP Committee hearing, Senator Bernie Sanders juxtaposed these maintenance costs against the operational failures at Steward hospitals. While the *Amaral* incurred $4 million in annual upkeep, Steward’s Good Samaritan Medical Center in Brockton, Massachusetts, faced serious absence of bone cutters and other surgical instruments due to unpaid vendor bills.

The 2025 Clawback Litigation

Following the criminal contempt referral, the focus shifted to the recovery of these assets. In July 2025, the restructuring officers for the Steward bankruptcy estate filed a detailed adversary proceeding against de la Torre and his associated entities, including Mullet Ltd. The lawsuit, filed in the U. S. Bankruptcy Court for the Southern District of Texas, sought to claw back the funds used to purchase the yacht under the theory of “fraudulent transfer.” The estate argued that the $111 million dividend in 2021 was issued while Steward was insolvent or was rendered insolvent by the transfer. Therefore, the purchase of the *Amaral* was financed with money that legally belonged to the hospital system’s creditors. The complaint explicitly stated: “De la Torre used the funds he received as a distribution from SHC System to fund the purchase of the Amaral… which he continues to enjoy to this day.” The legal action aimed to seize the vessel, liquidate it, and return the proceeds to the bankruptcy estate to pay outstanding debts to nurses, suppliers, and patients.

Senate Scrutiny and Public Outrage

The *Amaral* became a visceral prop during the Senate proceedings. During the September 12, 2024 hearing, large format photographs of the yacht were displayed in the committee room, standing in clear contrast to the empty witness chair reserved for de la Torre. Senator Sanders utilized the yacht to the defense that Steward’s failure was due to widespread market forces. “This is not a case of a hospital system failing due to rising costs,” Sanders stated. “This is a case of a CEO looting the hospital system to buy a $40 million yacht while patients died.” The specific identification of the *Amaral* and the *Jaruco* allowed the Committee to anchor their contempt charges in tangible evidence of malfeasance. The refusal of de la Torre to answer questions regarding the funding of these specific assets—even with the clear paper trail linking them to the 2021 dividend—strengthened the Committee’s justification for the criminal referral. The yacht ceased to be a boat; it became the primary exhibit of the “greed and bad faith misconduct” in the Senate’s final resolution.

The ‘Jaruco’ Sportfish: A $15 Million Secondary Vessel in the Corporate Fleet

While the 190-foot superyacht *Amaral* garnered the majority of headlines during the Senate HELP Committee hearings, investigators focused equal scrutiny on a “secondary” vessel in Ralph de la Torre’s armada: the *Jaruco*. A 90-foot custom sportfishing yacht delivered in late 2017, the *Jaruco* represents a specific, functional excess that parallels the operational stripping of Steward Health Care’s assets. Unlike the *Amaral*, which served as a floating palace for leisure, the *Jaruco* was a high-performance machine designed for competition, purchased and maintained with funds diverted from a hospital system already showing signs of financial.

Engineering Excess: The Carbon Fiber “Game Changer”

The *Jaruco* (Hull 62) was not a luxury purchase; it was commissioned as an engineering marvel from Jarrett Bay Boatworks in North Carolina. Delivered in December 2017, the vessel was marketed as the most advanced sportfish boat ever built. Its construction specifications reveal a fixation on performance at any cost, a clear contrast to the deferred maintenance and equipment absence Steward’s facilities during the same period. To achieve a top speed exceeding 40 knots and a range capable of reaching remote Pacific fisheries, the vessel utilized advanced materials reserved for aerospace or Formula 1 racing. * **Carbon Fiber Construction:** The *Jaruco* featured carbon fiber stringers, bulkheads, and decks, shedding approximately 30, 000 to 40, 000 pounds compared to traditional cold-molded construction. * **Titanium Components:** The propeller shafts were forged from titanium rather than stainless steel, saving over 1, 000 pounds and adding significant expense. * **Range:** With a fuel capacity of 4, 400 gallons, the vessel was designed for long-range expeditions, far removed from the communities Steward served.

Marine industry publications from 2018 hailed the vessel as a “game changer” and a finalist for global design awards. For the Senate HELP Committee, yet, these specifications served as evidence of where capital expenditures were prioritized. While Steward hospitals in Massachusetts and Texas struggled to replace aging MRI machines and fix leaking roofs, the corporate leadership authorized the construction of a vessel optimized for the specific hobby of its CEO.

“Team Jaruco” and the Tournament Circuit

The *Jaruco* was not a passive asset. It served as the platform for “Team Jaruco,” a competitive angling team led by de la Torre. Senate investigators tracked the vessel’s movements to high- fishing tournaments, including the prestigious Los Sueños Signature Triple Crown in Costa Rica.

The juxtaposition of “Team Jaruco” celebrating podium finishes in Costa Rica while Steward nurses reportedly purchased their own cleaning supplies created a visceral image for the Committee. During the September 12, 2024 hearing, Senator Ed Markey (D-MA) referenced these “floating assets” as direct evidence of the “looting” of the hospital system. The vessel’s operation required a full-time crew, significant fuel outlays, and specialized maintenance, costs that bankruptcy filings suggest were absorbed by Steward’s corporate accounts under the guise of “executive oversight” or travel expenses.

The Financial Web: Funding the Fleet

Tracing the ownership of the *Jaruco* required forensic accounting to penetrate a labyrinth of limited liability companies. Unlike the *Amaral*, which was frequently linked to the 2021 dividend recapitalization, the *Jaruco* appears to have been funded through earlier capital extractions, chance linked to the 2016 sale-leaseback deal with Medical Properties Trust (MPT). Defense attorneys for de la Torre have argued that the *Jaruco* was a personal asset purchased prior to the system’s most acute insolvency. A “fact check” website launched by de la Torre’s legal team in September 2024 claimed the boat was “paid for in 2015,” attempting to decouple it from the 2024 bankruptcy. yet, the *Jaruco* was not delivered until late 2017, and significant payments for its custom outfitting continued well into 2018, a period when Steward was already failing to pay vendors within contract terms.

“The construction of the *Jaruco* involved millions in milestone payments between 2015 and 2017. Every dollar spent on titanium shafts and carbon fiber decking was a dollar not spent on patient care reserves. The timeline of this build perfectly overlaps with the beginning of the end for Steward’s financial solvency.”
, Testimony from Senate HELP Committee Staff Report, September 2024

Bankruptcy and Clawback Proceedings

In the aftermath of the May 2024 Chapter 11 filing, the *Jaruco* became a target for the bankruptcy estate’s “clawback” litigation. In July 2025, Steward Health Care filed an adversary complaint against de la Torre and other insiders, explicitly seeking to recover funds used for “lavish personal expenditures.” While the *Amaral* ($40 million) was the primary target, the *Jaruco* ($15 million) was identified as part of the broader pattern of asset diversion. By late 2024, reports indicated the vessel had been quietly marketed, with an asking price fluctuating between $15 million and $18 million. Unlike the corporate jets, which were seized and sold relatively quickly to cover immediate debts, the specialized nature of the *Jaruco*—a custom tournament boat rather than a standard luxury yacht—complicated its liquidation. As of December 2025, the proceeds from any chance sale of the *Jaruco* remain a contested asset, claimed by both the bankruptcy estate to pay creditors and by federal authorities investigating chance criminal fraud. The *Jaruco* remains a potent symbol in the Senate’s investigation: a vessel engineered for speed and extraction, owned by a CEO who fled the jurisdiction of his own failing hospitals.

Flight Logs: Corporate Jet Usage Amidst Hospital Resource absence

While Steward Health Care’s hospitals faced serious supply absence, infrastructure failures, and vendor non-payments, the company maintained a fleet of luxury aircraft for the exclusive use of its CEO, Ralph de la Torre. Flight logs and corporate records from 2022 through 2024 reveal a pattern of travel to resort destinations that coincided directly with the system’s most severe operational crises. The between the capital allocated for executive travel and the funds available for basic patient care became a central focus of the Senate HELP Committee’s investigation.

The “Head of State” Fleet

Steward Health Care, through its affiliate Management Health Services (MHS), owned and operated two Bombardier Global 6000 aircraft. These jets, valued at approximately $62 million each when new, are marketed by the manufacturer as being designed for “world leaders” and offer a range of 6, 000 nautical miles. The Senate panel estimated the combined value of the pair at $95 million. One aviation analyst in local reporting described the Global 6000 as “Air Force One without the president.”

The aircraft featured high-speed internet, staterooms, and showers, allowing for non-stop travel between continents. Between 2022 and 2023 alone, these jets completed 582 flights. Analysis by the Boston Globe Team indicated that nearly half of these trips were to destinations more than 100 miles from any Steward hospital or corporate office, including locations such as the Galapagos Islands, the Amalfi Coast, and South Africa.

Timeline of Travel vs. Hospital Crises

The following table juxtaposes specific periods of executive travel with concurrent operational failures at Steward facilities. This data was corroborated by flight tracking software, bankruptcy filings, and internal hospital incident reports.

Resource Allocation Disparities

The operational costs of the Bombardier Global 6000s were borne by Steward Health Care, even with the company’s insolvency. Bankruptcy filings and Senate testimony revealed that de la Torre received at least $250 million in compensation over a four-year period. In 2021, a $111 million dividend was authorized for the company’s owners; de la Torre’s share was approximately $81. 5 million. Shortly after this payout, he purchased the 190-foot superyacht Amaral for an estimated $40 million.

During the same period, infrastructure at Steward hospitals due to deferred maintenance. At St. Elizabeth’s Medical Center in Brighton, nurses testified that only one of six elevators was functional in January 2024. Staff were forced to use transport sleds to drag patients down stairwells during emergencies. In Florida, the HVAC system at Rockledge Regional Medical Center failed, leading to humidity levels that compromised sterile environments. The pest control vendor for the bat infestation at Rockledge sued for non-payment, citing nearly $1 million in arrears.

Ownership and Liquidation

The aircraft were held by Management Health Services, a subsidiary that charged Steward hospitals millions in “management fees” to cover overhead, including the flight operations. This structure funneled hospital revenue, derived largely from Medicare and Medicaid reimbursements, into the maintenance of the executive fleet. Following the Chapter 11 bankruptcy filing in May 2024, the status of the jets became a point of contention for creditors. The Senate HELP Committee’s investigation highlighted that while the company could not afford to pay for life-saving embolism coils, it continued to fund the fuel, pilots, and hangar fees for trans-Atlantic travel until the final months of operation.

The juxtaposition of the “Versailles” trip against the closure of Nashoba Valley and Carney hospitals served as a catalyst for the criminal contempt proceedings. Lawmakers argued that the flight logs provided physical evidence of gross mismanagement and a prioritization of personal luxury over public health obligations.

Clinical Mortality: The Preventable Death of Sungida Rashid at St. Elizabeth’s

The criminal contempt proceedings against Dr. Ralph de la Torre were not predicated solely on abstract financial malfeasance on specific clinical outcomes that the Senate Health, Education, Labor, and Pensions (HELP) Committee identified as direct consequences of Steward Health Care’s insolvency. Among the cases examined by the committee, the death of 39-year-old Sungida Rashid in October 2023 at St. Elizabeth’s Medical Center in Brighton, Massachusetts, served as the primary evidentiary link between corporate non-payment of vendors and preventable patient mortality.

The Clinical Event: October 2023

On a date in early October 2023, Sungida Rashid was admitted to St. Elizabeth’s Medical Center for the delivery of her daughter. The delivery initially appeared routine, and Rashid was able to hold her newborn. yet, shortly after the birth, she began to experience significant postpartum hemorrhaging, a known obstetrical emergency that requires immediate intervention to prevent exsanguination. Medical staff at St. Elizabeth’s identified the source of the bleeding as a liver abnormality and determined that the standard of care required an embolization coil, a minimally invasive device inserted into a blood vessel to obstruct flow and stop internal bleeding. The interventional radiology team prepared to deploy the device, a standard inventory item for a Level 2 trauma center and major teaching hospital.

Supply Chain Failure and Vendor Repossession

When the surgical team attempted to retrieve the embolization coil, they discovered the inventory was empty. Senate testimony and subsequent investigations by the *Boston Globe* and federal regulators revealed that the coils were not missing due to a logistical error or a national absence. They had been physically repossessed weeks earlier by the manufacturer, Penumbra, Inc. Records during the HELP Committee’s investigation indicated that Steward Health Care had failed to pay Penumbra for an extended period, accumulating an outstanding debt of approximately $2. 5 million. Following months of non-payment, the vendor placed St. Elizabeth’s on a credit hold and retrieved its consignment inventory. This administrative decision, driven by the parent company’s refusal to settle accounts payable, left the clinical team without the specific tool required to save Rashid’s life.

Transfer and Mortality

absence the necessary equipment to control the on-site, the medical team at St. Elizabeth’s was forced to transfer Rashid to a different facility better equipped to manage the emergency. The delay inherent in stabilizing and transporting a serious unstable patient proved fatal. Rashid suffered cardiac arrest and died shortly after the transfer, leaving behind her husband and newborn daughter.

Testimony of Ellen MacInnis

The details of Rashid’s death were formally entered into the Senate record during the September 12, 2024, hearing. Ellen MacInnis, a nurse at St. Elizabeth’s Medical Center and a member of the Massachusetts Nurses Association, provided testimony that anchored the committee’s inquiry in clinical reality. MacInnis described the conditions at the hospital as “tragic,” explicitly linking the absence of supplies, ranging from bereavement boxes for deceased infants to life-saving surgical tools, to the corporate diversion of funds.

“She may have been saved by a device known as an embolism coil. There weren’t any in the hospital. There hadn’t been any in the hospital for weeks. They had been repossessed by the vendor. She died.”
, Ellen MacInnis, Nurse at St. Elizabeth’s Medical Center, testifying before the Senate HELP Committee, September 12, 2024.

Committee Findings on Causality

The HELP Committee utilized the Rashid case to the defense that Steward’s bankruptcy was a result of market forces or low reimbursement rates. Senators Bernie Sanders (I-VT) and Ed Markey (D-MA) juxtaposed the $2. 5 million debt to Penumbra against the personal expenditures of Dr. Ralph de la Torre during the same fiscal quarter. Committee exhibits showed that while the embolization coils were being repossessed, de la Torre continued to fund the operation of his 190-foot yacht, the *Amaral*, and a $7 million sport fishing boat. The committee’s referral for criminal contempt argued that de la Torre’s refusal to testify prevented the Senate from questioning him on the specific decision-making process that prioritized executive compensation over the retention of serious surgical inventory. The death of Sungida Rashid thus became the central narrative element in the Senate’s argument that Steward’s management practices constituted a reckless endangerment of public health.

Supply Chain Collapse: Repossessed Embolism Coils and Unpaid Vendor Invoices

The criminal contempt proceedings against Ralph de la Torre were not a response to a procedural slight; they were the culmination of a widespread operational disintegration that had lethal consequences. By late 2023, Steward Health Care’s refusal to pay vendors had moved beyond administrative delays to a total supply chain collapse. The most devastating example of this failure occurred on October 4, 2023, at St. Elizabeth’s Medical Center in Brighton, Massachusetts. Sungida Rashid, a 39-year-old mother, died from a liver shortly after childbirth. Medical staff had identified the bleed and prepared to intervene, only to discover that the specific embolism coils required to stop the hemorrhaging were missing from the inventory.

Weeks prior to Rashid’s death, the manufacturer of the coils, Penumbra, had repossessed its stock from St. Elizabeth’s due to chronic non-payment of invoices. Hospital staff had previously warned executives that the removal of these devices posed an immediate threat to patient safety, yet the outstanding debts remained unsettled. This incident was not an clerical error the direct result of a corporate strategy that prioritized management fees and real estate lease payments over clinical solvency. When the Senate HELP Committee convened, this specific fatality served as primary evidence that the financial malfeasance under de la Torre’s leadership had crossed the threshold into negligent homicide.

The billion-Dollar Vendor Deficit

By the time Steward Health Care filed for Chapter 11 protection on May 6, 2024, the company had accumulated approximately $1 billion in unpaid obligations to vendors and suppliers. This debt load resulted in a widespread “credit hold” status across the network, forcing hospital administrators to plead for supplies or pay cash on delivery for serious items. The absence ranged from sophisticated surgical implants to basic sanitation supplies. In verified testimony, clinicians reported that orthopedic surgeries were cancelled because artificial joints were not shipped, and blood banks refused to release products without immediate payment.

The following table details a sample of the specific unpaid vendor invoices in court filings and lawsuits between 2023 and 2024, illustrating the breadth of the non-payment strategy:

Facility Decay: The Rockledge Bat Infestation

The operational neglect extended to the physical infrastructure of the hospitals. At Rockledge Regional Medical Center in Florida, the failure to pay maintenance vendors led to a severe pest infestation in 2023. Thousands of Brazilian free-tailed bats colonized the facility, with the infestation becoming so acute that the fifth-floor intensive care unit reeked of guano. In one documented incident, a patient in the ICU complained of being attacked by a “giant grasshopper,” which staff later identified as a bat clinging to the curtains.

Steward contracted Rentokil North America to perform “bat eviction” services failed to honor the contract. Rentokil subsequently filed a lawsuit in October 2023, alleging that Steward owed over $936, 000 specifically for the bat removal and a total of $1. 6 million for broader pest control services. This refusal to pay for basic sanitary maintenance occurred simultaneously with the transfer of millions in dividends to the company’s equity holders, a that Senators Sanders and Cassidy highlighted repeatedly during the contempt proceedings.

Testimony on the Dignity of Care

The human cost of these unpaid invoices was most vividly articulated by Ellen MacInnis, a nurse at St. Elizabeth’s Medical Center, who testified before the HELP Committee. Her account stripped away the financial abstraction of the bankruptcy, revealing the degradation forced upon frontline staff and patients. MacInnis described a supply chain so broken that it failed to provide even the most basic materials for grieving families.

“We also heard that Steward neglected to pay the vendors for essential hospital supplies. At St. Elizabeth’s, when newborn babies died, nurses were forced to put their bodies into cardboard shipping boxes because Steward did not pay for proper bereavement boxes.”

This testimony substantiated the committee’s position that the defiance of the subpoena was an attempt to conceal the extent of the operational collapse. The “bereavement box” detail became a focal point for the committee members, symbolizing the total abandonment of compassionate care standards in favor of financial extraction. The inability to procure cardboard boxes for deceased infants stood in clear contrast to the $40 million yacht, the Amaral, purchased by de la Torre during the same period of fiscal contraction.

The supply chain emergency was not a result of market forces or payer mix; it was a manufactured liquidity emergency. As Steward transferred cash to service the master lease with Medical Properties Trust (MPT), local accounts payable departments were left empty. By early 2024, the situation had to the point where Mass General Brigham withdrew its physicians from Holy Family Hospital due to the absence of safe surgical equipment. This withdrawal was a direct precursor to the state intervention and the eventual criminal referral, as it demonstrated that the facilities were no longer capable of functioning as hospitals in anything name.

Facility Decay: Pest Control Liens and Infrastructure Failure in Florida

While Steward Health Care’s executives touted the profitability of their Florida network, which reportedly generated $37. 7 million in profits in 2021, the physical reality inside these facilities told a different story. By 2023, the disconnect between corporate financial reports and the operational status of the hospitals had manifested in grotesque infrastructure failures. The most visceral example of this decay occurred at Rockledge Regional Medical Center in Brevard County, where financial negligence allowed a pest infestation to compromise the Intensive Care Unit.

The Rockledge Bat Infestation

In 2023, staff at Rockledge Regional Medical Center reported that thousands of bats had infested the facility, colonizing the upper floors. The infestation was concentrated on the fifth floor, which housed the hospital’s Intensive Care Unit (ICU). Conditions to the point where the ICU had to be temporarily relocated to ensure patient safety. Reports from the facility described a chaotic environment. In one documented incident, an ICU patient complained of being attacked by a “giant grasshopper,” which staff later identified as a bat. A nurse also reported finding a bat clinging to a patient’s curtain. The presence of bat guano created a hazardous environment, forcing the hospital to contract emergency extermination services.

Rentokil North America vs. Steward Health Care

Steward Health Care contracted Rentokil North America to handle the “bat eviction” and general pest control. Rentokil performed the work, which involved labor-intensive removal processes spanning nearly two months. Yet, consistent with its operational pattern across other states, Steward failed to pay the vendor for these serious services. In October 2023, Rentokil filed a lawsuit in the District Court for Dallas County, Texas, alleging that Steward owed more than $1. 6 million in unpaid bills. The breakdown of these charges highlighted the of the neglect: * **$936, 320** specifically for the bat removal services at Rockledge. * **$1. 3 million+** total sought for services rendered, interest, and legal fees. The lawsuit claimed that Steward executives made repeated pledge to pay failed to honor them. This non-payment was not an clerical error part of a widespread strategy of vendor suppression that extended to basic facility maintenance.

Surgical Stoppages and Equipment Repossession

The financial contagion spread beyond pest control to clinical operations. At Sebastian River Medical Center, the failure to pay medical device vendors directly impacted surgical schedules. Reports from *Vero Beach 32963* indicated that surgeries, including joint replacements, were cancelled or postponed because the hospital did not have the necessary artificial joints on hand. Vendors, owed millions, had placed the facility on credit hold, refusing to ship implants until past-due invoices were settled. By July 2024, bankruptcy filings revealed that Steward owed approximately $1 billion to vendors system-wide. This debt included unpaid invoices for: * **Elevator Repair:** Essential vertical transport for gurneys and patients faced service interruptions. * **Landscaping:** A landscaping company filed suit for over $59, 000 in unpaid bills for services at Brevard County hospitals. * **Infrastructure:** A door and glass company sued for over $50, 000 regarding unpaid installation of hospital doors.

Table: Selected Vendor Liens and Debts in Florida (2023-2024)

Senate HELP Committee Findings

These specific instances of decay became central evidence during the Senate HELP Committee’s investigation. Senator Bernie Sanders and the committee staff utilized these examples to the defense that Steward’s failure was solely due to market forces. The juxtaposition was clear: while Ralph de la Torre owned a $40 million yacht and a $15 million sportfishing boat, patients in his Florida hospitals were being treated in rooms infested with bats, and surgeons were forced to cancel procedures due to a absence of sterile implants. The committee’s contempt resolution against de la Torre was driven by his refusal to explain this. The “bat infestation” narrative, in particular, served as a potent symbol of the management negligence that the committee sought to criminalize. It demonstrated that the extraction of capital from the health system had crossed the line from financial engineering to physical endangerment of American citizens.

Market Contraction: The Closure of Carney Hospital and Nashoba Valley Medical Center

On the morning of August 31, 2024, at 7: 00 a. m., the emergency department doors at Carney Hospital in Dorchester and Nashoba Valley Medical Center in Ayer locked permanently. The closures marked the physical liquidation of assets in the Steward Health Care bankruptcy, transforming abstract financial malfeasance into a concrete public health emergency. While Ralph de la Torre remained absent from the proceedings, 1, 243 employees received termination notices, and two distinct Massachusetts populations, one urban and low-income, the other rural and , were stripped of their primary medical lifelines.

The “No Qualified Bids” Verdict

The route to closure was paved in a Houston courtroom on July 31, 2024. During a hearing before U. S. Bankruptcy Judge Christopher Lopez, Steward’s attorneys argued that even with an aggressive marketing campaign, neither facility had attracted a “qualified bid.” The definition of “qualified” proved pivotal: while there was interest, no chance buyer was or able to assume the exorbitant lease obligations attached to the underlying real estate, which was owned by Medical Properties Trust (MPT). Judge Lopez, describing the decision as “painful,” authorized the closures to proceed on an accelerated timeline, overriding Massachusetts state law which mandates a 120-day notice period for hospital shutdowns. The court accepted Steward’s argument that keeping these “money-losing” facilities open threatened the liquidity of the entire system, sacrificing two hospitals to save the remaining six.

Data of the Displacement

The liquidation resulted in the immediate removal of serious infrastructure from the Massachusetts healthcare grid. The following table details the verified losses incurred on August 31, 2024.

The Rural emergency: Nashoba Valley

The closure of Nashoba Valley Medical Center created an immediate “ambulance desert” in north-central Massachusetts. For decades, the facility served as the primary stabilization point for towns like Ayer, Groton, and Shirley. With its closure, local fire chiefs reported that transport times for emergency services tripled. Prior to August 31, the average ambulance run from Ayer to the nearest emergency room was approximately 2. 7 miles, taking roughly 12 minutes. Following the closure, ambulances were forced to divert to UMass Memorial HealthAlliance in Leominster or Emerson Hospital in Concord. This increased the travel distance to between 12 and 16 miles, with round-trip turnaround times extending to over an hour. This “out-of-service” time meant that local fire departments were frequently left without available units to respond to subsequent 911 calls, a scenario Ayer Fire Chief Timothy Johnston described as “unsustainable.”

The Urban Void: Carney Hospital

In Dorchester, the closure of Carney Hospital exacerbated severe inequities in Boston’s healthcare. Carney was a safety-net institution, serving a patient population that was predominantly low-income and publicly insured. Of particular concern was the loss of 70 psychiatric beds, a resource already in serious absence across the Commonwealth. The Boston City Council and public health advocates labeled the closure a civil rights problem, noting that the displacement forced residents, of whom absence private transportation, to travel significantly farther to already overcrowded emergency rooms at Boston Medical Center and Beth Israel Deaconess. The removal of Carney turned parts of Dorchester into what the Massachusetts Nurses Association termed a “pharmaceutical desert,” where access to acute care and prescriptions became logistically prohibitive for the elderly and infirm.

Regulatory Impotence and the 120-Day Rule

The closures exposed the limitations of state regulatory power in the face of federal bankruptcy protection. Massachusetts law requires hospitals to provide 120 days’ notice before closing essential services to allow the Department of Public Health (DPH) to find alternatives. Steward provided barely 35 days’ notice. Although the DPH held mandatory public hearings in August, one at Florian Hall in Dorchester and another at the Devens Common Center, these proceedings were largely performative. State regulators admitted they absence the legal authority to override a federal bankruptcy judge’s order. Governor Maura Healey, while publicly condemning the “greed and mismanagement” of Ralph de la Torre, focused the state’s financial firepower on saving the remaining five Steward hospitals, allocating $30 million in Medicaid advances to their transfer to new operators. Carney and Nashoba Valley were excluded from this rescue package, sealing their fate.

The Backdrop to Contempt

These closures provided the visceral context for the Senate HELP Committee’s September proceedings. When the committee convened on September 12, the “empty chair” reserved for Ralph de la Torre was not a symbol of procedural non-compliance; it represented a CEO who was reportedly sailing off the coast of Corsica while 1, 243 of his employees were processing unemployment claims and ambulances in Ayer were driving past a boarded-up emergency room. The tangible harm inflicted on these communities stripped De la Torre of any remaining political cover, unifying the committee in its resolve to pursue criminal contempt charges.

The October 1 Departure: A Strategic Exit

On October 1, 2024, Ralph de la Torre officially resigned as Chairman and CEO of Steward Health Care, ending a fourteen-year tenure that began with the acquisition of Caritas Christi Health Care and concluded in the largest hospital bankruptcy in decades. The resignation, immediately, was not a sudden capitulation a calculated legal maneuver executed just days after the full Senate voted to refer him for criminal prosecution.

The timing of the departure, less than one week after the Senate’s unanimous contempt vote, suggests a strategy to de-escalate congressional pressure while pivoting to a defense against looming federal inquiries. In a statement released through a spokesperson, de la Torre characterized the separation as “amicable” and on “mutually agreeable terms,” a phrasing that clear contrasted with the radioactive nature of his standing in Washington and the operational reality of the bankrupt health system.

The “Amicable” Severance Narrative

While the specific financial mechanics of de la Torre’s exit package were shielded by non-disclosure agreements at the time of his resignation, the public characterization of the split as “amicable” implied the retention of significant benefits. A spokesperson for the former CEO stated that de la Torre would “continue to be a tireless advocate for the improvement of reimbursement rates for the underprivileged patient population,” a comment that drew immediate bipartisan ire given the closure of safety-net hospitals under his watch.

Senator Ed Markey (D-MA) immediately rejected the narrative of a clean break, stating on September 28, 2024, that the resignation was “not enough” and that de la Torre “must be held accountable in the court of law.” The disconnect between the corporate press release and the legislative fury highlighted the parallel realities de la Torre navigated: a boardroom where he negotiated an exit, and a hearing room where he was a fugitive witness.

De la Torre’s Counter-Offensive: Suing the Senate

Just one day prior to his official resignation, on September 30, 2024, de la Torre filed a federal lawsuit against the Senate HELP Committee. The complaint, lodged in the U. S. District Court for the District of Columbia, sought a declaratory judgment that the subpoena issued by the committee was invalid and that his invocation of the Fifth Amendment precluded him from being compelled to testify.

The lawsuit argued that the committee’s true objective was not legislative inquiry “public ridicule,” claiming the senators intended to “brand him a criminal” in a televised spectacle. By filing suit immediately before stepping down, de la Torre attempted to frame his refusal to testify as a constitutional principle rather than an evasion of corporate accountability. This legal action froze the dialogue between the former CEO and the committee, shifting the venue from the Dirksen Senate Office Building to the federal courts.

The $1. 4 Billion Clawback: Steward Turns on Its Founder

The “amicable” nature of de la Torre’s October 2024 departure disintegrated nine months later. In July 2025, the bankruptcy estate of Steward Health Care filed a blistering lawsuit against de la Torre and other insiders, seeking to recover approximately $1. 4 billion in alleged fraudulent transfers and excessive compensation. This litigation shattered the façade of the “mutually agreeable” separation.

The complaint, filed in the U. S. Bankruptcy Court for the Southern District of Texas, alleged that de la Torre and his inner circle “pilfered” the company’s assets while the hospitals faced insolvency. The suit specifically targeted a $111 million dividend recapitalization from 2021, of which de la Torre personally received approximately $81. 5 million. The filing detailed how these funds were allegedly diverted to purchase luxury assets, including the $40 million yacht Amaral and a 500-acre ranch in Waxahachie, Texas, even as the company deferred maintenance and stiffed vendors.

“These insiders pilfered Steward’s assets for their own material gain, while leaving the Company and its hospitals perpetually undercapitalized and insolvent. Their misconduct led to Steward’s collapse.”
, Steward Health Care Bankruptcy Filing, July 17, 2025

The Collapse of the Golden Parachute

The July 2025 lawsuit nullified any severance protections de la Torre might have negotiated in October 2024. By accusing him of breaching his fiduciary duty and engaging in “greed and bad faith misconduct,” the bankruptcy estate moved to claw back not just severance payments, years of compensation. The litigation marked the final transition of de la Torre from the architect of the Steward system to its primary antagonist, with the very corporate entity he founded serving as the vehicle for his financial.

This legal pincer movement, criminal contempt charges from the Senate on one flank and a billion-dollar civil fraud suit from his former company on the other, defined de la Torre’s status in late 2025. The resignation in October 2024, intended to close a chapter, instead served as the prologue to a protracted legal siege.

Bankruptcy Court Docket 24-90213: Judge Christopher Lopez’s Oversight in Houston

While the Senate HELP Committee prepared its criminal contempt case in Washington, a parallel legal drama unfolded 1, 400 miles away in the United States Bankruptcy Court for the Southern District of Texas. Docket No. 24-90213, filed on May 6, 2024, placed the collapse of Steward Health Care under the jurisdiction of Judge Christopher M. Lopez. This venue became the operational fulcrum for the system’s liquidation and, crucially, the shield Ralph de la Torre attempted to wield against congressional oversight.

The “Federal Court Order” Defense

On September 4, 2024, de la Torre’s legal team, led by Alexander Merton, invoked the proceedings in Houston as a primary justification for his refusal to testify. In a letter to the committee, Merton argued that a “federal court order” regarding mediation confidentiality prohibited de la Torre from discussing the financial matters under Senate inquiry. This argument relied on the standard protective orders issued by Judge Lopez to settlement talks between Steward and its landlord, Medical Properties Trust (MPT). yet, a review of the bankruptcy docket reveals no specific ruling by Judge Lopez that explicitly barred de la Torre from complying with the congressional subpoena. The court’s protective orders were designed to prevent the public disclosure of sensitive negotiation details during asset sales, not to grant immunity from legislative process. Legal experts noted that the “police power” exception allows government enforcement actions, including congressional investigations, to proceed even with a bankruptcy stay. Judge Lopez, focused on the solvency of the estate, did not intervene to quash the Senate’s subpoena, leaving de la Torre’s defense to rest on his counsel’s interpretation rather than a direct judicial prohibition.

Liquidation and Closures: August 2024

Inside Courtroom 401 at 515 Rusk Street, the priority was not executive accountability the immediate cash flow emergency threatening patient care. Throughout August 2024, Judge Lopez presided over a series of emergency hearings to authorize the sale or closure of Steward’s assets. On July 31, 2024, Judge Lopez approved the closure of two Massachusetts hospitals, Carney Hospital in Dorchester and Nashoba Valley Medical Center in Ayer, after no qualified bidders emerged. During the hearing, Lopez described the decision as “painful” legally necessary to prevent the entire system’s financial collapse. “To keep those hospitals open, based upon the evidence before me, threatens the entire hospital system in Massachusetts,” Lopez stated. This ruling resulted in the layoff of 1, 243 employees and the loss of serious emergency services, fueling the political firestorm that would culminate in the Senate’s contempt vote weeks later. By September 4, 2024, the same day de la Torre’s lawyers sent their refusal letter to the Senate, Judge Lopez approved the sale of six remaining Massachusetts hospitals for approximately $343 million. The buyers included Boston Medical Center, Lifespan, and Lawrence General Hospital. In a move to resolve a dispute with secured lenders, Lopez ordered $17 million of the proceeds withheld, demonstrating the court’s tight control over every dollar entering the estate.

The Estate Turns on the CEO: July 2025

The separation between the bankruptcy estate and its former CEO widened significantly in 2025. Following de la Torre’s resignation on October 1, 2024, the restructured Steward Health Care System, under the control of independent fiduciaries, launched a legal offensive against its former leadership. On July 15, 2025, the bankruptcy estate filed a scathing adversary proceeding (lawsuit) against Ralph de la Torre and other executives. The complaint, lodged within the main bankruptcy case, sought to claw back over $100 million in alleged fraudulent transfers. The filing accused de la Torre of “pilfering” the company’s assets, specifically citing a $111 million dividend issued in 2021 when the company was allegedly insolvent. The estate’s lawyers detailed how de la Torre received $81. 5 million of this dividend, a portion of which was reportedly used to purchase a $40 million yacht, the *Amaral*. This lawsuit marked a pivotal shift: the bankruptcy court, once by de la Torre as a reason for his silence, had become the venue for his financial prosecution. The estate’s allegations mirrored the Senate’s findings, accusing the former CEO of prioritizing personal enrichment over patient safety and vendor obligations.

Plan Confirmation: July 25, 2025

The bankruptcy process reached its definitive conclusion on July 25, 2025, when Judge Lopez confirmed Steward Health Care’s Chapter 11 liquidation plan. The plan, approved after the resolution of over 50 objections, established a liquidation trust to distribute remaining assets to creditors and a litigation trust to pursue claims against third parties, including the pending action against de la Torre. The confirmation hearing underscored the of the financial devastation. The plan estimated that general unsecured creditors, including thousands of vendors and former employees, would receive only pennies on the dollar. Judge Lopez rejected motions to convert the case to a Chapter 7 liquidation, arguing that the confirmed plan offered the best remaining route for recovery.

The Judicial-Legislative Disconnect

The proceedings in Houston highlighted a fundamental disconnect between the judicial and legislative branches. For Judge Lopez, the primary statutory directive was the maximization of the estate’s value and the orderly transfer of healthcare assets under the Bankruptcy Code. For the Senate HELP Committee, the objective was accountability for the widespread failure. De la Torre exploited this gap, using the procedural complexity of the bankruptcy court to delay his appearance before Congress. yet, the court’s eventual authorization of the lawsuit against him in July 2025 demonstrated that the bankruptcy process was not a sanctuary. While Judge Lopez did not force de la Torre to the witness table in the Dirksen Senate Office Building, his courtroom provided the legal method to the former CEO’s financial legacy. The “federal court order” that de la Torre invoked to silence the Senate had, by 2025, authorized the very estate he once commanded to sue him for fraud.

The Optum Transaction: Attempted Sale of Stewardship Health Physician Network

The centerpiece of Ralph de la Torre’s strategy to stave off total liquidation in early 2024 rested on a single, high- transaction: the sale of **Stewardship Health**, the system’s physician network, to **Optum**, a subsidiary of UnitedHealth Group. Announced in March 2024, this deal was positioned not as a divestiture as an immediate liquidity lifeline designed to fund Steward’s operations through a pre-arranged bankruptcy process. ### The Proposed Lifeline Stewardship Health comprised a network of primary care physicians and clinicians across nine states. For Steward, the sale represented the only viable route to secure “debtor-in-possession” (DIP) financing. Lenders, including Medical Properties Trust, had conditioned approximately **$75 million** in immediate loans on the successful execution of this sale. The transaction was intended to transfer thousands of physicians to Optum, which already employs more than 10% of all doctors in the United States, so consolidating UnitedHealth Group’s vertical dominance in the healthcare market. ### Regulatory Blockade The deal immediately faced intense scrutiny from state and federal regulators, who viewed the consolidation as a threat to market competition. * **Department of Justice (DOJ) Intervention:** On May 28, 2024, the DOJ’s Antitrust Division filed a formal objection in the U. S. Bankruptcy Court for the Southern District of Texas. Principal Deputy Assistant Attorney General Brian Boynton argued that Steward’s proposed timeline for the sale was aggressively accelerated to bypass necessary antitrust review. The DOJ explicitly stated that the bankruptcy process could not be used to “short-circuit” federal law. * **Massachusetts Health Policy Commission (HPC):** State regulators in Massachusetts required a material change notice to review the transaction’s impact on costs and access. yet, Steward and Optum failed to submit a definitive agreement, preventing the 30-day review clock from ever starting. * **Congressional Opposition:** Senators Elizabeth Warren and Ed Markey publicly the deal, warning that allowing UnitedHealth to acquire Steward’s doctors would raise antitrust concerns and fail to guarantee the survival of the remaining hospitals. ### Collapse of the Deal On **June 27, 2024**, Optum formally abandoned the transaction. While the company did not problem a public press release detailing its reasons, reports confirmed that the decision was driven by the of a criminal investigation into Steward Health Care by the U. S. Department of Justice based in Boston. This investigation reportedly examined chance fraud and violations of the Foreign Corrupt Practices Act, rendering Steward a radioactive counterparty for a publicly traded giant like UnitedHealth Group. The collapse of the Optum deal shattered Steward’s bankruptcy roadmap. Without the “anchor” transaction, the company was forced to pivot to a fire sale of its assets. In August 2024, Steward eventually agreed to sell Stewardship Health to **Rural Healthcare Group**, an affiliate of private equity firm Kinderhook Industries, for **$245 million**, a figure finalized only after a chaotic auction process.

Timeline of the Failed Transaction

“The debtors have represented they intend to use the proposed sale to United as a ‘stalking horse’ bid… [This] interferes with the United States’ antitrust review.”
, Brian Boynton, Principal Deputy Assistant Attorney General, DOJ (May 28, 2024 Filing)

The Statutory Mandate: 2 U. S. C. § 194 and the “Duty” to Prosecute

The transmission of Senate Resolution 837 to the Department of Justice on September 25, 2024, triggered a specific, century-old statutory method. Under 2 U. S. C. § 194, once the President of the Senate certifies a contempt citation, the statute dictates the step with rigid precision. It states that it “shall be the duty” of the U. S. Attorney “to bring the matter before the grand jury for its action.” This language, “shall be the duty”, historically stripped federal prosecutors of the discretion they enjoy in criminal matters. Unlike standard criminal referrals where the DOJ weighs evidence and public interest, § 194 was designed to be a mandatory conveyor belt from the Capitol to the grand jury room. yet, modern judicial interpretations and Department of Justice policies have eroded this imperative, transforming a statutory command into a discretionary review. The recipient of this referral was Matthew M. Graves, the U. S. Attorney for the District of Columbia. Appointed by President Biden, Graves had previously overseen the aggressive prosecution of Steve Bannon and Peter Navarro for similar contempt charges. Yet, in the case of Ralph de la Torre, the of justice ground to a halt. Unlike the Bannon and Navarro cases, which moved from referral to indictment in 26 and 60 days respectively, the de la Torre file sat on the U. S. Attorney’s desk for over a year without public movement.

Comparative Timeline of Contempt Prosecutions (2021, 2025)

The in processing times reveals a clear contrast between political contempt cases and the corporate contempt of Ralph de la Torre.

The Defensive Shield: De la Torre v. Sanders

Five days after the Senate’s referral, on September 30, 2024, de la Torre executed a legal maneuver designed to freeze the DOJ’s hand. He filed a federal lawsuit, *De la Torre v. Sanders*, in the U. S. District Court for the District of Columbia, naming Chairman Bernie Sanders and the HELP Committee members as defendants. The lawsuit argued that the committee’s subpoena was a “law enforcement” action disguised as legislation, intended solely to “humiliate” him for the Steward Health Care bankruptcy. De la Torre’s legal team, led by high-profile defense counsel, asserted that compelling his testimony would violate his Fifth Amendment rights against self-incrimination, given the parallel criminal investigations into Steward’s financial collapse. This “pre-enforcement challenge” created a tactical delay. While the Department of Justice is not legally bound to pause a grand jury presentation during civil litigation, federal prosecutors frequently use such pending suits as a rationale to defer action. For nearly twelve months, the criminal referral languished while the civil docket churned.

The Dismissal: September 2025

The legal stalemate broke on September 16, 2025. U. S. District Judge Trevor McFadden issued a decisive ruling dismissing de la Torre’s lawsuit. Judge McFadden, an appointee of Donald Trump known for his strict adherence to constitutional text, grounded his decision in the Speech or Debate Clause of the Constitution. In his opinion, McFadden held that the court absence jurisdiction to enjoin the Senate’s legislative activity. The issuance of a subpoena and the voting of contempt were “integral parts of the deliberative and communicative processes” of Congress, rendering the Senators immune from suit. The court rejected de la Torre’s claim that the investigation was purely punitive, noting that the HELP Committee’s inquiry into private equity in health care fell squarely within its legislative jurisdiction.

“The judiciary cannot serve as a referee for every dispute between a congressional committee and a witness. The Speech or Debate Clause provides an absolute bar to this action. Dr. de la Torre’s remedy lies in his defense against a criminal prosecution, should one ever be brought, not in a preemptive strike against the legislature.”
, Judge Trevor McFadden, Memorandum Opinion, Sept 16, 2025

Political Transition and Executive Inaction

By the time Judge McFadden cleared the route for prosecution in late 2025, the political in Washington had shifted fundamentally. The Department of Justice was no longer under the direction of Merrick Garland. Following the 2024 election, the new administration appointed Pam Bondi as Attorney General. This transition introduced a new variable into the calculus of prosecution. While the Biden DOJ had aggressively pursued contempt charges against Trump allies, the new leadership faced a different test: enforcing congressional authority against a corporate executive. On September 19, 2025, three days after the lawsuit’s dismissal, Senator Ed Markey (D-MA) sent a blistering letter to Attorney General Bondi. Markey, a primary architect of the Steward investigation, highlighted the “dangerous signal” sent by the Department’s continued silence. “Nearly one year has passed since the Senate unanimously voted to hold Dr. de la Torre in contempt,” Markey wrote. “even with the seriousness of this referral, there has been no visible enforcement. This inaction signals that executives can evade accountability simply by ignoring congressional subpoenas.” As of March 2026, the U. S. Attorney’s Office for the District of Columbia has yet to impanel a grand jury or return an indictment against Ralph de la Torre. The “duty” mandated by 2 U. S. C. § 194 remains unfulfilled, leaving the Senate’s unanimous censure as a symbolic gesture rather than a legal consequence. The empty chair at the hearing room has been replaced by a silent file in the prosecutor’s office, raising fundamental questions about the equality of law when corporate power collides with congressional oversight.

Legislative Aftermath: The Health Over Wealth Act and Private Equity Reform

The Steward Catalyst: From Scandal to Statute

The collapse of Steward Health Care did not result in the criminal referral of its CEO; it served as a potent accelerant for dormant legislative efforts to regulate private equity’s encroachment into the American healthcare system. For years, policy experts had warned that the “strip-and-flip” model, whereby investors acquire hospitals, sell their real estate, and load the operating companies with debt, posed a widespread risk to patient safety. The Steward bankruptcy, leaving 31 hospitals in financial ruin and triggering a public health emergency in Massachusetts, transformed these theoretical warnings into urgent political capital. By late 2024 and early 2025, the Senate HELP Committee’s investigation had catalyzed a multi-pronged legislative response aimed at the financial engineering method that allowed Ralph de la Torre and Cerberus Capital Management to extract wealth from community hospitals.

S. 4804: The Health Over Wealth Act

On July 25, 2024, Senator Ed Markey (D-MA), chair of the HELP Subcommittee on Primary Health and Retirement Security, introduced the Health Over Wealth Act (S. 4804). Unlike previous transparency bills, S. 4804 proposed a fundamental restructuring of how private equity firms interact with clinical entities. The legislation was directly informed by the specific failures identified during the Steward investigation, particularly the opacity of the system’s financial entanglements with Medical Properties Trust (MPT).

The Act’s most aggressive provision the “capital extraction” model. It mandates that private equity-owned health care facilities establish an escrow account containing sufficient funds to cover five years of operating expenses. This requirement is designed to prevent the sudden closures seen in the Steward network, where hospitals like Carney Hospital and Nashoba Valley Medical Center were shuttered with little notice due to liquidity crises.

Key Provisions of the Health Over Wealth Act (S. 4804):

• Licensing Regime: Private equity firms must obtain a license from the Department of Health and Human Services (HHS) to invest in health care entities. HHS is granted authority to revoke these licenses if firms engage in price gouging or understaffing.
• REIT Oversight: The bill requires a rigorous review of any sale-leaseback transaction between a health care provider and a Real Estate Investment Trust (REIT). It regulators to block deals that would weaken the provider’s financial stability.
• Transparency: Mandates public reporting of debt loads, executive compensation, lobbying expenditures, and reductions in clinical services.
• Bankruptcy Priority: In the event of insolvency, the Act elevates the claims of workers and patients above those of investors in bankruptcy proceedings.

The “Teeth” of Reform: Corporate Crimes Against Health Care Act

While the Health Over Wealth Act focused on regulation and stability, the Corporate Crimes Against Health Care Act of 2024, introduced by Senator Elizabeth Warren (D-MA) on June 11, 2024, sought to impose punitive consequences for the type of “looting” alleged in the Steward case. This legislation introduced a new criminal penalty: up to six years in federal prison for executives whose financial mismanagement of a health care entity results in the death of a patient.

The bill also addresses the problem of “unjust enrichment” that dominated the September 2024 hearings. It grants the Department of Justice and state attorneys general the authority to claw back compensation, including salaries, bonuses, and stock gains, paid to private equity and portfolio company executives within a 10-year window leading up to a financial collapse. This provision was explicitly drafted to target the estimated $250 million paid to Ralph de la Torre and the $800 million profit realized by Cerberus Capital Management, sums that remained untouched by the bankruptcy court’s initial rulings. also, the Act proposes a ban on federal health payments (Medicare and Medicaid) to entities that sell their assets to REITs, outlawing the sale-leaseback model for any hospital reliant on public funding.

Massachusetts House Bill 5159: The Concrete Ban

While federal legislation faced the slow churn of the congressional committee process, the Commonwealth of Massachusetts moved swiftly to enact state-level protections. On January 8, 2025, Governor Maura Healey signed House Bill 5159, “An Act Enhancing the Market Review Process,” into law. This statute stands as the in the nation to explicitly prohibit the future sale of acute care hospital real estate to REITs, directly outlawing the method that precipitated Steward’s downfall.

The Massachusetts law also expanded the powers of the Health Policy Commission (HPC) and the Center for Health Information and Analysis (CHIA). It requires significant equity investors to disclose audited financial statements and the Attorney General to scrutinize upstream investors, not just the hospital operators, for chance violations of the False Claims Act. This pierces the corporate veil that private equity firms frequently use to shield their assets from liability when their portfolio companies commit fraud.

Industry Pushback and the route Forward

The legislative push triggered a vigorous counter-campaign from the private equity industry. The American Investment Council (AIC), the primary lobbying group for the sector, argued that private capital is essential for modernizing healthcare infrastructure and keeping rural hospitals open. In a letter to the Senate HELP Committee on September 12, 2024, the AIC contended that private equity owns less than 4% of U. S. hospitals by revenue and that the Steward case was an outlier rather than a representative example of the industry’s impact.

even with this opposition, the bipartisan fury directed at Ralph de la Torre suggested a shifting consensus. The unanimous Senate vote to hold de la Torre in contempt signaled that the era of deference to financialized healthcare models was ending. By linking the abstract concepts of leveraged buyouts and REITs to the visceral reality of shuttered emergency rooms and unpaid nurses, the Steward Health Care bankruptcy forced lawmakers to confront a serious question: whether the maximization of shareholder wealth is compatible with the preservation of human life. As 2025 progressed, the “Steward Rule”, the principle that financial engineering must not compromise clinical care, began to harden from political rhetoric into regulatory reality.